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CORRECTION Open Access
Correction to: Small Molecule KRAS Agonist
for Mutant KRAS Cancer Therapy
Ke Xu1, Dongkyoo Park1, Andrew T. Magis2, Jun Zhang3, Wei Zhou4, Gabriel L. Sica5, Suresh S. Ramalingam4,
Walter J. Curran1 and Xingming Deng1*
Correction to: Mol Cancer (2019) 18:85
https://doi.org/10.1186/s12943-019-1012-4
Following the publication of the original article [1], the
authors spotted error in Fig. 1C. The colony formation
image of H1792 in control row was accidently placed
the same image of H322. This is a mistake and has to be
corrected. Now, the actual image of H1792 in control
row is placed at H1792 spot in revised Fig. 1 (below).
This correction does not change any conclusions made
in the article. The authors apologize for this error and
any confusion it may have caused.
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